Articles with "gnrha" as a keyword



Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).

Sign Up to like & get
recommendations!
Published in 2020 at "European journal of cancer"

DOI: 10.1016/j.ejca.2020.03.030

Abstract: BACKGROUND This study assessed the effects of gonadotropin-releasing hormone agonists (GnRHa) on the prevention of chemotherapy-induced ovarian insufficiency among young patients with malignant ovarian germ cell tumour (MOGCT) receiving chemotherapy. METHODS This multicentre, retrospective study… read more here.

Keywords: chemotherapy; releasing hormone; menstrual resumption; gonadotropin releasing ... See more keywords

Maintenance Therapy for Preventing Endometrioma Recurrence after Endometriosis Resection Surgery-A Systematic Review and Network Meta-analysis.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of minimally invasive gynecology"

DOI: 10.1016/j.jmig.2021.11.024

Abstract: OBJECTIVE To evaluate the efficacy of different hormone therapies in preventing postoperative endometrioma recurrence. DATA SOURCES The MEDLINE, COCHRANE and Embase electronic databases were searched from inception to 30 April 2021. METHODS OF STUDY SELECTION… read more here.

Keywords: analysis; endometrioma recurrence; recurrence; therapy ... See more keywords

A mouse model mimicking gender-affirming treatment with pubertal suppression followed by testosterone in transmasculine youth.

Sign Up to like & get
recommendations!
Published in 2022 at "Human reproduction"

DOI: 10.1093/humrep/deac257

Abstract: STUDY QUESTION Can mice serve as a translational model to examine the reproductive consequences of pubertal suppression with GnRH agonist (GnRHa) followed by testosterone (T) administration, a typical therapy in peripubertal transmasculine youth? SUMMARY ANSWER… read more here.

Keywords: gnrha; transmasculine youth; model; treatment ... See more keywords

Effect of GnRHa on plasma levels of Fsh and Lh in the female greater amberjack Seriola dumerili.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of fish biology"

DOI: 10.1111/jfb.14137

Abstract: The effects of gonadotropin-releasing hormone agonist (GnRHa) on plasma levels of follicle-stimulating hormone (Fsh) and luteinising hormone (Lh) are reported for female greater amberjack Seriola dumerili with post-vitellogenic ovarian oocytes. Five females were implanted with… read more here.

Keywords: gnrha plasma; greater amberjack; female greater; plasma levels ... See more keywords

The efficacy and safety of rhGH treatment combined with letrozole/GnRHa in adolescent boys

Sign Up to like & get
recommendations!
Published in 2025 at "BMC Pediatrics"

DOI: 10.1186/s12887-025-05408-y

Abstract: In boys during puberty who were undergoing recombinant human growth hormone (rhGH) treatment, we compared the therapeutic efficacy on growth, and any adverse reactions, of co-therapy with either letrozole or gonadotropin-releasing hormone analog (GnRHa). Fifty-six… read more here.

Keywords: rhgh; group; gnrha; letrozole group ... See more keywords

Pubertal Suppression in Early Puberty Followed by Testosterone Mildly Increases Final Height in Transmasculine Youth.

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of the Endocrine Society"

DOI: 10.1210/jendso/bvae089

Abstract: Context Treatment for transmasculine youth (TMY) can involve testosterone treatment and is sometimes preceded by gonadotropin-releasing hormone agonist (GnRHa) treatment for puberty blockade. GnRHas can increase final height in birth-assigned females with central precocious puberty.… read more here.

Keywords: height; treatment; youth; puberty ... See more keywords

SUN-132 Effectiveness of 6-Month Gnrha Formulations for Pubertal Suppression in Youth Assigned Male-At-Birth

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of the Endocrine Society"

DOI: 10.1210/jendso/bvaf149.2066

Abstract: Abstract Disclosure: N. Sun: None. M. Vargas Trujillo: Abbvie, Consultant. G. Chelvakumar: None. M. Marinkovic: None. Introduction: Pubertal suppression with gonadotropin-releasing hormone agonists (GnRHa) is a core component of gender-affirming care for transgender and non-binary… read more here.

Keywords: month; suppression; youth; pubertal suppression ... See more keywords

GnRH agonist treatment for idiopathic central precocious puberty can improve final adult height in Chinese girls

Sign Up to like & get
recommendations!
Published in 2017 at "Oncotarget"

DOI: 10.18632/oncotarget.22568

Abstract: Object To study the outcomes of GnRHa on final adult height in Chinese idiopathic central precocious puberty (ICPP) girls and the involved factor(s) that can predict height gain. Methods We conducted a retrospective analysis on… read more here.

Keywords: adult; adult height; therapy; final adult ... See more keywords

Effect of Exogenous Luteinizing Hormone (LH) Supplementation on Clinical Pregnancy of Patients Receiving Long-Acting Gonadotropin-Releasing Hormone Agonist (GnRHa) Cycles: A Retrospective Cohort Study

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Women's Health"

DOI: 10.2147/ijwh.s388726

Abstract: Purpose Timely and moderate luteinizing hormone (LH) secretion plays critical roles in follicle development and maturation. However, the role of LH supplementation in in vitro fertilization/intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET) cycles remains unclear.… read more here.

Keywords: gnrha; hormone; supplementation; clinical pregnancy ... See more keywords

Reproductive Outcome After GnRH Agonist Triggering With Co-Administration of 1500 IU hCG on the Day of Oocyte Retrieval in High Responders: A Long-Term Retrospective Cohort Study

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Endocrinology"

DOI: 10.3389/fendo.2022.826411

Abstract: While triggering oocyte maturation with GnRH agonist (GnRHa) seems to be safe and effective in terms of the risk of developing OHSS and the number of metaphase II oocytes, it nevertheless results in luteal phase… read more here.

Keywords: gnrha; day oocyte; outcome; hcg day ... See more keywords

HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Endocrinology"

DOI: 10.3389/fendo.2022.876517

Abstract: Background GnRH agonist (GnRHa) pretreatment before the frozen-thawed embryo transfer (FET) was increasingly utilized. However, the incidence of GnRHa-induced functional ovarian cysts (FC) was inevitable. The feasibility and efficacy of HCG triggering GnRHa-induced FC are… read more here.

Keywords: gnrha; hcg triggering; clinical pregnancy; rate ... See more keywords